Day: June 16, 2023

At the close of business on 15 June 2023, Morten Opstad,Member of the Board of IDEX Biometrics, held the following voting rights in IDEX, for the purpose of the Annual General Meeting on 16 June 2023: Total 361,187,305 shares or 28,09% of the share capital and votes, consisting of the following:Proxy to represent and vote for 176,123,962 shares or 13,70% of the share capital, including shares held by Mr Opstad and close relations Proxy with voting instructions for 185,063,343 shares or 14,39% of the share capital.For further information contact: Marianne Bøe, Head of Investor Relations E-mail: marianne.boe@idexbiometrics.com Tel: + 47 918 00186 About IDEX Biometrics IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control,...

Hepsor SPV I Ltd, a subsidiary of Hepsor in the Canadian province of Ontario, made its first investment in the Canadian real estate market. A property suitable for residential development was purchased in Toronto at 3406-3434 Weston Road together with Canadian partners. Weston Limited Partnership was founded in order to develop the property in which, in addition to Hepsor and its Canadian partners, various Canadian and European investors also participate. Fasken (www.fasken.com), one of Canada’s largest law firms, advised Hepsor on structuring the deal. The goal of the first phase of the acquired development project is to increase the construction volumes of the property from 27,000 m2 to ca 53,000 m2 and to obtain construction rights for the creation of two apartment buildings. The land valuation phase is expected to take 2-2.5...

BOSTON, June 15, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced the pricing of its underwritten public offering of 55,150,000 shares of its common stock at a public offering price per share of $0.95 and, in lieu of shares of common stock, a pre-funded warrant to purchase up to an aggregate of 7,050,000 shares of common stock at a purchase price of $0.9499, which equals the public offering price per share of the common stock less the $0.0001 per share exercise price of each pre-funded warrant. The gross proceeds from the offering are expected to be approximately $59.1 million, before...

Figure 1 Mt Cattlin Cross section Looking EastFigure 2 Mt Cattlin Stage 4 Open Pit PlanFigure 3 Mt Cattlin Stage 4 Open Pit PlanFigure 4 NPV Sensitivity to Key Revenue and Cost Factor VariablesSection 1 Sampling Techniques and DataSection 2 Reporting of Exploration ResultsBRISBANE, Australia, June 15, 2023 (GLOBE NEWSWIRE) — Allkem Limited (ASX: AKE, “Allkem” or the “Company”) provides an Ore Reserve update for its Mt Cattlin operation in Western Australia (“WA“). HIGHLIGHTSOre Reserve tonnage increased 34% to 7.8Mt at 1.20% Li2O and 130ppm Ta2O5 at a cut-off grade of 0.4% Li2O. The Ore Reserve and planned mining schedule suggests a projected Life-of-Mine for the next 4-5 years (2027-2028) via open pit mining methods. The Ore Reserve has increased with higher grade despite mining depletion to support production....

— Publication shows FRESCO-2 demonstrated treatment with fruquintinib reduced the risk of death by 34% in previously treated metastatic colorectal cancer (0.66 HR) — — Data support regulatory submissions in the U.S., Europe and Japan during 2023 — HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J. and OSAKA, Japan and CAMBRIDGE, Mass., June 15, 2023 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM, HKEX:​13) and Takeda (TSE:4502, NYSE:TAK) today announced that results of the Phase III FRESCO-2 study evaluating fruquintinib in patients with previously treated metastatic colorectal cancer (“CRC”) were published in The Lancet.   The publication provides details of the FRESCO-2 study results as of June 24, 2022. Summary results from this cut-off date were presented on September 12, 2022, at the European Society...

WATERLOO, Ontario, June 15, 2023 (GLOBE NEWSWIRE) — The Descartes Systems Group Inc. announced the voting results from its annual meeting of shareholders held on Thursday, June 15, 2023 (the “Meeting”). Meeting Results The following matters, as set out in more detail in its Management Information Circular dated May 10, 2023, were considered and voted on by shareholders at the Meeting: General The total number of common shares of the Corporation represented in person or by proxy at the Meeting was 75,061,434 which represented 88.23% of the 85,078,029 common shares of the Corporation that were outstanding on May 2, 2023 Election of DirectorsOn a vote by ballot, each of the following 10 nominees proposed by management of the Corporation was elected as a director of the Corporation:Director Nominee Number of Votes FOR Percentage...